-
Mashup Score: 0Medtronic Receives FDA Indication for Bifurcation Percutaneous Coronary Intervention with a Drug-eluting Stent - 2 year(s) ago
September 21, 2022 — Medtronic announced today that it has received Food and Drug Administration (FDA) approval for the treatment of non-left main bifurcation lesions utilizing the provisional bifurcation stenting technique (using a single stent to treat the bifurcation) with the Onyx Frontier drug-eluting stent (DES) and the Resolute Onyx DES.1 This indication will allow Medtronic to provide a…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy - 2 year(s) ago
If you don’t remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your passwordIf the address matches a valid account an email will be sent to __email__ with instructions for resetting your password …
Source: www.jscai.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Favaloro Live Case 28 - ATC al Tronco de CI con IVL - 2 year(s) ago
Operadores:O. MendizC. FavaInstituto de Cardiología y Cirugía Cardiovascular del Hospital Universitario Fundación FavaloroSuscribite a mi canal: https://bit….
Source: YouTubeCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Favorable Outcomes for Orsiro DES presented at EuroPCR in the Five-Year BIO-RESORT Small Vessels Subgroup Analysis - 2 year(s) ago
July 5, 2022 — A BIO-RESORT subgroup analysis of outcomes in small coronary vessels (
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 10Multiple Coronary Aneurysms Post–Drug-Eluting Stenting: A Rare Case of Hypersensitivity Reaction - 2 year(s) ago
∗Address for correspondence: Dr Kevin Ka-ho Kam, Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, New Territories, Hong Kong SAR, China. E-mail: E-mail Address: khkam1102@gmail.com.
Categories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 0MedAlliance’s SELUTION SLR Drug-eluting Balloon Receives FDA Investigational Device Exemption Approval - 2 year(s) ago
May 27, 2022 — The SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained drug release, similar to a drug-eluting stent (DES). SELUTION SLR was also the first DEB granted “Breakthrough Device Designation” by the FDA on March 4, 2019 and further on September 25, 2019 for below-the-knee (BTK) indications in peripheral artery disease. “This…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 6Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention: - 2 year(s) ago
Abstract Objectives The purpose of this study was to assess the extent to which the association between premature dual antiplatelet therapy (DAPT) discontinuation and excess risk of thrombotic even…
Categories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Comparison of Contemporary Drug-Eluting Stents in Patients Undergoing Complex High-Risk Indicated Procedures: - 2 year(s) ago
Abstract Background Limited data are available on the relative performances of diverse contemporary drug-eluting stents (DES) in patients undergoing complex high-risk indicated procedures (CHIP). O…
Source: JACC: AsiaCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 0EuroIntervention - 2 year(s) ago
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Source: EuroInterventionCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 9Improved 3-Year Cardiac Survival After IVUS–Guided Long DES Implantation: A Patient-Level Analysis From 2 Randomized Trials - 2 year(s) ago
Abstract Objectives The present study aimed to evaluate long-term cardiac survival benefit for intravascular ultrasound (IVUS)- versus angiography-guided long drug-eluting stent (DES) implantation….
Categories: Cardiac Surgery, Latest HeadlinesTweet
@DAICeditor @Medtronic Medtronic received #FDA approval for the treatment of non-left main bifurcation lesions utilizing the provisional #bifurcation #stenting technique with the #OnyxFrontier drug-eluting stent (#DES) and the #ResoluteOnyxDES: https://t.co/0vJIKG2TYB